-
Most Popular
Search Results
240 results for icgn
Hottest Healthcare Stocks Now – IMGN HZNP IRWD MACK
Healthcare stocks finished up 0.4% on Wall Street on Tuesday.
Hottest Healthcare Stocks Now – CLDX LCI IMGN ALNY
Healthcare stocks finished up 0.6% on Wall Street today. NASDAQ:CLDX, NYSE:LCI, NASDAQ:IMGN, NASDAQ:ALNY, NASDAQ:ACAD, NYSE:PBYI, NASDAQ:MGLN, NASDAQ:ALXN, NASDAQ:LGND, NASDAQ:ACOR, NASDAQ:ISIS, NASDAQ:ISRG, NYSE:EXAM, NYSE:STE, NYSE:CNC, NASDAQ:SIRO,…
Hottest Healthcare Stocks Now – INCY IMGN TECH LCI
Healthcare stocks finished up 0.3% on Wall Street on Tuesday.
Hottest Healthcare Stocks Now – PBYI ISIS EXAS IMGN
Healthcare stocks advanced 0.7% on Wall Street so far on Monday.
Hottest Healthcare Stocks Now – AGN CLDX IMGN VRX
Healthcare stocks rose broadly on Wall Street today, with the sector seeing an overall increase of 0.3%.
Hottest Healthcare Stocks Now – MYGN MNKD IMGN IRWD
Healthcare stocks declined on Wall Street on Friday morning, down 0.2%.
Hottest Healthcare Stocks Now – QCOR IMGN LCI PCRX
Healthcare stocks rose broadly on Wall Street so far on Wednesday, with the sector seeing an overall increase of 0.4%. NASDAQ:QCOR, NASDAQ:IMGN, NYSE:LCI, NASDAQ:PCRX, NASDAQ:CLDX,…
10 Lessons for Investing From Vanguard Icon Jack Bogle
Investing icon Jack Bogle capped his final book, ‘The Clash of the Cultures,’ with an important list of 10 things every investor should learn.
Once an IOU to Creditors, Iconic Blue Oval Returns to Ford
Years after having to use its brand and logos as collateral to avoid bankruptcy, Ford’s debt is upgraded, allowing the automaker to reclaim its blue…
Virgin Icon Richard Branson Invests in Upscale Hotel Upstart
Investing icon Richard Branson has created a multi-billion dollar media company, been knighted in England and has even crossed the Pacific Ocean in a hot-air…
Sara Lee Sheds Iconic Name, Becomes Hillshire Brands
Sara Lee is changing its iconic name to Hillshire Brands Company and spinning off its coffee and tea business in Europe.
Sell-the-News Moment Is Your Chance to Reload on Ocugen
As Ocugen – or at least, a partner in developing a Covid-19 vaccine – receives a critical approval, OCGN stock could rebound soon.
Former Dumpster Fire Ocugen Makes a Compelling Bull Case
You don’t need to analyze much to realize that OCGN stock is an incredibly risky trade. Nevertheless, the political necessity of an effective vaccine against…
WHO Approval Should Get Ocugen Stock Over the $15 Barrier
Sharp up-and-down moves in OCGN stock shouldn’t scare investors away, as a regulator’s nod for Covaxin should put the stock back on track.
Cynicism and Conspiracy Theories Could Help Ocugen
While OCGN stock seems well behind the vaccination race to be worth a shot, there is one narrative that could potentially help.
Ocugen Proves Groupthink Is a Double-Edged Sword
While OCGN stock is an intriguing idea on the science, when the masses have a different framework, it becomes a risky proposition.
ImmunoGen Stock Is in Trouble Going Into Earnings
IMGN stock is falling into a bottomless pit, but therein lies an opportunity. You can take a bet on a surprise upside run in ImmunoGen.
Ocugen Stock Is Essentially Back to Being an Eye Disease Play
OCGN stock has a tough path to entry in the North American market and time is not on its side
Ocugen Just Overcame a Serious Hurdle
OCGN stock has skyrocketed on positive Phase 3 results. But the company is facing tough competition.
What the WHO Snub Means For Ocugen Stock Investors?
Add the World Health Organization’s suspension of Covaxin to the list of troubles that are weighing down OCGN stock.
If the FDA Can’t Help Ocugen Stock, You Have to Wonder Who Can
Because of the pandemic, OCGN stock attracts speculative interest. But it is not likely to pay off in the long-run
Don’t Chase Ocugen Stock Without Reading the Fine Print
OCGN stock has soared on positive vaccine data. But investors must remember that Ocugen’s market and experience are sharply limited.
It’s Time to Get Clinical, Not Cynical, With Ocugen Stock
The selling pressure on OCGN stock has been as heavy as a rock, but worried shareholders should celebrate Ocugen’s breakthrough moments.
With No Vaccine Approval, Ocugen Is the Definition of Dead Money
Holding out hope for a Covid vaccine approval that might never come, OCGN stock is too risky while the company has no revenue.
6 – 10 of 240 results
